Comparison of the electroencephalographic and motor effects of orphenadrine, an antiparkinson agent.
D000818:Animals; D001143:Arousal / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003864:Depression, Chemical; D004558:Electric Stimulation; D004569:Electroencephalography; D007275:Injections, Intravenous; D008297:Male; D008615:Mephenesin / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009966:Orphenadrine / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D011817:Rabbits; D012601:Scopolamine / Q000494:pharmacology; D013268:Stimulation, Chemical; D003336:Tectum Mesencephali / Q000187:drug effects
D008615:Mephenesin; D001285:Atropine; D009966:Orphenadrine; D012601:Scopolamine; D010424:Pentobarbital; D002746:Chlorpromazine